NovoCure Limited

NASDAQ: NVCR · Real-Time Price · USD
16.99
0.54 (3.28%)
At close: Jun 06, 2025, 3:57 PM
17.00
0.06%
After-hours: Jun 06, 2025, 04:01 PM EDT

Revenue by Geography

Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
China Revenue 17.39M 23.22M 21.33M 22.77M 12.59M 5.25M 6.35M 303K 89K
China Revenue Growth -25.14% +8.87% -6.29% +80.82% +139.58% -17.26% +1996.04% +240.45% n/a
France Revenue 55.73M 60.21M 46.12M 93.94M 93.26M 86.56M 168.41M 134.69M 72.77M
France Revenue Growth -7.44% +30.55% -50.90% +0.72% +7.74% -48.60% +25.04% +85.08% n/a
Germany Revenue 65.26M 136.37M 32.78M 34.64M 29.08M 17.91M n/a n/a n/a
Germany Revenue Growth -52.14% +316.01% -5.37% +19.14% +62.33% n/a n/a n/a n/a
International Markets Revenue 196.03M 31.67M 406.89M 353.11M 340.78M 232.81M n/a n/a n/a
International Markets Revenue Growth +519.03% -92.22% +15.23% +3.62% +46.38% n/a n/a n/a n/a
Japan Revenue 32.57M 349.74M n/a n/a n/a n/a n/a n/a n/a
Japan Revenue Growth -90.69% n/a n/a n/a n/a n/a n/a n/a n/a
United States Revenue 391.8M n/a n/a n/a n/a n/a n/a n/a n/a
United States Revenue Growth n/a n/a n/a n/a n/a n/a n/a n/a n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 100.56M 139.89M 99.93M 94.35M 94.74M 98.64M 99.85M 99.27M 93.11M 87.7M 73.9M 76.42M 68.39M 69.99M 63.81M 66.9M 62.48M 59.72M 56.42M 53.87M 55.44M 50.55M 46.54M 44.96M 42.57M 40.28M 37.98M 37.4M 35.46M 32.48M 31.6M 31.38M 27.18M 28.68M 28.59M 27.63M 25.56M 25.84M 17.32M 16.23M 13.33M
Selling, General, and Administrative Revenue Growth -28.12% +39.99% +5.91% -0.40% -3.95% -1.22% +0.59% +6.61% +6.17% +18.67% -3.29% +11.73% -2.29% +9.69% -4.61% +7.07% +4.62% +5.84% +4.75% -2.84% +9.67% +8.62% +3.52% +5.60% +5.70% +6.05% +1.54% +5.48% +9.18% +2.78% +0.70% +15.47% -5.22% +0.30% +3.47% +8.08% -1.07% +49.18% +6.70% +21.79% n/a
Research and Development Revenue 53.78M 51.21M 51.88M 54.95M 51.6M 54.31M 53.62M 55.43M 59.7M 54.82M 51.96M 57.08M 42.23M 56.93M 48.14M 50.31M 45.92M 44M 32.82M 29.92M 25.27M 23.74M 18.77M 19.45M 17.04M 15.03M 13.07M 11.36M 11.1M 10.05M 9.27M 9.37M 9.41M 8.47M 10.23M 11.32M 11.45M 10.85M 10.21M 12.77M 9.93M
Research and Development Revenue Growth +5.01% -1.30% -5.59% +6.51% -4.99% +1.28% -3.25% -7.16% +8.91% +5.51% -8.97% +35.14% -25.82% +18.26% -4.32% +9.58% +4.35% +34.08% +9.69% +18.39% +6.44% +26.51% -3.54% +14.15% +13.36% +14.99% +15.07% +2.32% +10.51% +8.36% -1.05% -0.43% +11.10% -17.22% -9.59% -1.11% +5.53% +6.21% -20.01% +28.59% n/a
Sales and Marketing Revenue 55.79M 67.41M 59.83M 56.62M 55.21M 59.19M 57.96M 58.49M 51.17M 49.63M 41.4M 44.75M 37.88M 38.98M 32.58M 34.14M 31.36M 31.36M 29.36M 28.46M 28.83M 26.8M 23.83M 23.71M 22.33M 21.21M 19.12M 19.2M 18.14M 16.02M 16.39M 16.36M 14.76M 15.68M 15.87M 14.6M 13.31M 14.72M 8.92M 8.87M 6.36M
Sales and Marketing Revenue Growth -17.24% +12.67% +5.68% +2.55% -6.73% +2.11% -0.90% +14.30% +3.10% +19.89% -7.50% +18.12% -2.82% +19.65% -4.56% +8.87% -0.01% +6.79% +3.17% -1.29% +7.57% +12.48% +0.51% +6.16% +5.30% +10.90% -0.38% +5.85% +13.17% -2.21% +0.17% +10.87% -5.88% -1.18% +8.68% +9.69% -9.62% +65.14% +0.56% +39.51% n/a